- AZN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
20-F/A Filing
AstraZeneca (AZN) 20-F/A2011 FY Annual report (foreign) (amended)
Filed: 21 Sep 12, 12:00am
1. | I have reviewed this Amendment No. 1 to the annual report on Form 20-F of AstraZeneca PLC; and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
/s/ Simon Lowth | |
Simon Lowth, Interim Chief Executive Officer, AstraZeneca PLC |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.